![Jay Stout](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Stout
Hoofd Techniek/Wetenschap/O&O bij
IMMUNOVANT, INC.
Vermogen: 7 M $ op 31-05-2026
Profiel
Jay S.
Stout is Chief Technology Officer at Immunovant, Inc. since 2023.
Formerly, Dr. Stout was Chief Technical Officer at Immunomedics, Inc. and Senior Vice President-Technical Operations at Versartis, Inc. Education includes undergraduate and graduate degrees from the University of Iowa and a doctorate from The University of Nebraska-Lincoln.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMMUNOVANT INC 0,1% | 26-06-2026 | 211.685 ( 0,1% ) | 7 M $ | 31-05-2026 |
Actieve functies van Jay Stout
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNOVANT, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2023 |
Eerdere bekende functies van Jay Stout
| Bedrijven | Functie | Einde |
|---|---|---|
| IMMUNOMEDICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Jay Stout
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
The University of Nebraska-Lincoln
 The University of Nebraska-Lincoln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
